As Questions Grow, Duke Halts Trials, Launches Investigation

摘要

When biostatisticians Keith Baggerly and Kevin Coombes began poking around a cancer study back in 2006, they never imagined the furor that would eventually follow. Their questions about a prominent genetics group at Duke University in Durham, North Carolina, not only raised doubts about a popular method of tumor analysis but also led to accusations that a cancer researcher, Anil Potti, had padded his resume. Clinical trials at Duke based on these methods have been suspended, Duke is investigating the researcher in question, and there are calls for a general review of the field.